Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBRACE II: Radiochemotherapy and Adaptive Brachytherapy in Cervical Cancer
NCT03617133Phase 2Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Apr 2016
- Primary completion
- Dec 2021
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in Uterine Cervical Neoplasms, sponsored by Medical University of Vienna. Started Apr 2016; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
Uterine Cervical Neoplasms
Beyond the preview
Go deeper on NCT03617133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617133.